Contact Your Provider: Call your clinic in Seattle or San Francisco to report the symptom, especially if it happens after every injection
In June 2026 the MHRA approved the Wegovy pill (oral semaglutide 25 mg), the first oral GLP-1 medicine licensed in the UK specifically for weight management
CMS Transmittal 13673 (CR 14392) updated the MPFSDB effective April 6, 2026
Step 4 Ongoing Weight Loss & Quarterly Monitoring Once your dose is stable and youre progressing consistently, youll move into a rhythm of monitoring
For studies with measurements of plasma insulin and glucagon concentrations, plasma was collected by tail vein bleeding at timepoints 0, 60, 120 and 240 min
But many questions remain including its long-term safety profile, effect on lean body mass and bone mineral density, real-world tolerability, and ultimate UK pricing once and if MHRA approval is granted